273 related articles for article (PubMed ID: 36060936)
1. Deep learning reveals cuproptosis features assist in predict prognosis and guide immunotherapy in lung adenocarcinoma.
Li G; Luo Q; Wang X; Zeng F; Feng G; Che G
Front Endocrinol (Lausanne); 2022; 13():970269. PubMed ID: 36060936
[TBL] [Abstract][Full Text] [Related]
2. Identification and validation of a novel cuproptosis-related signature as a prognostic model for lung adenocarcinoma.
Chen Y; Tang L; Huang W; Zhang Y; Abisola FH; Li L
Front Endocrinol (Lausanne); 2022; 13():963220. PubMed ID: 36353226
[TBL] [Abstract][Full Text] [Related]
3. [Construction of Lung Adenocarcinoma Prognosis Model and Drug Sensitivity Analysis Based on Cuproptosis Related Genes].
Sun J; Zhang H; Liu H; Dong Y; Wang P
Zhongguo Fei Ai Za Zhi; 2023 Aug; 26(8):591-604. PubMed ID: 37752539
[TBL] [Abstract][Full Text] [Related]
4. Identification and validation of a novel cuproptosis-related stemness signature to predict prognosis and immune landscape in lung adenocarcinoma by integrating single-cell and bulk RNA-sequencing.
Yang J; Liu K; Yang L; Ji J; Qin J; Deng H; Wang Z
Front Immunol; 2023; 14():1174762. PubMed ID: 37287976
[TBL] [Abstract][Full Text] [Related]
5. Cuproptosis-related lncRNA predict prognosis and immune response of lung adenocarcinoma.
Wang F; Lin H; Su Q; Li C
World J Surg Oncol; 2022 Sep; 20(1):275. PubMed ID: 36050740
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatics construction and experimental validation of a cuproptosis-related lncRNA prognostic model in lung adenocarcinoma for immunotherapy response prediction.
Li L; Cai Q; Wu Z; Li X; Zhou W; Lu L; Yi B; Chang R; Zhang H; Cheng Y; Zhang C; Zhang J
Sci Rep; 2023 Feb; 13(1):2455. PubMed ID: 36774446
[TBL] [Abstract][Full Text] [Related]
7. Cuproptosis-related signature predicts prognosis, immunotherapy efficacy, and chemotherapy sensitivity in lung adenocarcinoma.
Wu G; Hu Q; Chen H; He M; Ma H; Zhou L; Xu K; Ren H; Qi J
Front Oncol; 2023; 13():1127768. PubMed ID: 37007124
[TBL] [Abstract][Full Text] [Related]
8. Cross-talk between cuproptosis and ferroptosis regulators defines the tumor microenvironment for the prediction of prognosis and therapies in lung adenocarcinoma.
Shen Y; Li D; Liang Q; Yang M; Pan Y; Li H
Front Immunol; 2022; 13():1029092. PubMed ID: 36733399
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis of cuproptosis-related genes in immune infiltration and prognosis in lung adenocarcinoma.
Xiaona X; Liu Q; Zhou X; Liang R; Yang S; Xu M; Zhao H; Li C; Chen Y; Xueding C
Comput Biol Med; 2023 May; 158():106831. PubMed ID: 37037146
[TBL] [Abstract][Full Text] [Related]
10. Role of cuproptosis-related gene in lung adenocarcinoma.
Liu Y; Lin W; Yang Y; Shao J; Zhao H; Wang G; Shen A
Front Oncol; 2022; 12():1080985. PubMed ID: 36620594
[TBL] [Abstract][Full Text] [Related]
11. Identification and integration analysis of a novel prognostic signature associated with cuproptosis-related ferroptosis genes and relevant lncRNA regulatory axis in lung adenocarcinoma.
Wang T; Jiang X; Lu Y; Ruan Y; Wang J
Aging (Albany NY); 2023 Mar; 15(5):1543-1563. PubMed ID: 36881404
[TBL] [Abstract][Full Text] [Related]
12. A cuproptosis-related long non-coding RNA signature to predict the prognosis and immune microenvironment characterization for lung adenocarcinoma.
Ma S; Zhu J; Wang M; Zhu J; Wang W; Xiong Y; Jiang R; Seetharamu N; Abrão FC; Puthamohan VM; Liu L; Jiang T
Transl Lung Cancer Res; 2022 Oct; 11(10):2079-2093. PubMed ID: 36386454
[TBL] [Abstract][Full Text] [Related]
13. Identification of cuproptosis and immune-related gene prognostic signature in lung adenocarcinoma.
Zhang W; Qu H; Ma X; Li L; Wei Y; Wang Y; Zeng R; Nie Y; Zhang C; Yin K; Zhou F; Yang Z
Front Immunol; 2023; 14():1179742. PubMed ID: 37622116
[TBL] [Abstract][Full Text] [Related]
14. Developing CuS for Predicting Aggressiveness and Prognosis in Lung Adenocarcinoma.
Liu H; Che H; Zhang M; Lv J; Pu C; Wu J; Zhang Y; Gu Y
Genes (Basel); 2023 May; 14(5):. PubMed ID: 37239416
[TBL] [Abstract][Full Text] [Related]
15. The characterization of tumor microenvironment infiltration and the construction of predictive index based on cuproptosis-related gene in primary lung adenocarcinoma.
Li K; Wu LL; Wang H; Cheng H; Zhuo HM; Hao Y; Liu ZY; Li CW; Qian JY; Li ZX; Xie D; Chen C
Front Oncol; 2022; 12():1011568. PubMed ID: 36505852
[TBL] [Abstract][Full Text] [Related]
16. Definition of a Novel Cuproptosis-Relevant lncRNA Signature for Uncovering Distinct Survival, Genomic Alterations, and Treatment Implications in Lung Adenocarcinoma.
Wang Z; Yao J; Dong T; Niu X
J Immunol Res; 2022; 2022():2756611. PubMed ID: 36281357
[TBL] [Abstract][Full Text] [Related]
17. Molecular subtypes based on cuproptosis-related genes and immune profiles in lung adenocarcinoma.
Wang Y; Zhang C; Ji C; Jin W; He X; Yu S; Guo R
Front Genet; 2022; 13():1006938. PubMed ID: 36313439
[No Abstract] [Full Text] [Related]
18. Cuproptosis-related gene signatures for predicting prognosis of lung adenocarcinoma.
Ye W; Huang Y; Li X
Medicine (Baltimore); 2022 Oct; 101(40):e30446. PubMed ID: 36221373
[TBL] [Abstract][Full Text] [Related]
19. Relationships of Cuproptosis-Related Genes With Clinical Outcomes and the Tumour Immune Microenvironment in Hepatocellular Carcinoma.
Chen X; Hu G; Xiong L; Xu Q
Pathol Oncol Res; 2022; 28():1610558. PubMed ID: 36213162
[No Abstract] [Full Text] [Related]
20. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
